Status: Recruiting
Short-term Glucocorticoid Combined with MMF for IgG4-RD
Comparison of short-term glucocorticoid monotherapy and short-term glucocorticoid combined with MMF in the treatment of IgG4 Related Disease
Participants needed: 63
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Wen ZhangUpdated: Oct 29, 2024Locations: 1
Eligibility criteria
18-80 years old; [+3]
Combined with other autoimmune diseases as the main diagnosis. [+4]